Regulation of homoeopathic and related medicines in a joint Australia New Zealand therapeutic products agency
December 2004
- This consultation closed on 11 March 2005.
This paper invites comment from stakeholders on the regulatory arrangements for homoeopathic and related medicines in the joint Australia New Zealand therapeutic products agency (the joint Agency).
The Australian and New Zealand Governments have agreed to harmonise the regulatory arrangements for therapeutic goods between both countries. Under the joint Agency, products represented to be for therapeutic use are to be regulated as therapeutic products. This includes homoeopathic and related medicines and products containing homoeopathic preparations.
This current consultation process offers stakeholders the opportunity to identify matters that will need to be considered in the development of a risk-based approach to the regulation of these products. This consultation paper outlines the current regulatory system for homoeopathic medicines (see Appendix 1) and poses a number of questions in relation to issues that have been identified with this system.

